Haematologica (Feb 2007)

The V617F mutation of JAK2 is very uncommon in patients with thrombosis

  • Angel F. Remacha,
  • Camino Estivill,
  • M. Pilar Sarda,
  • José Mateo,
  • Joan Carles Souto,
  • Carme Canals,
  • Josep Nomdedéu,
  • Jordi Fontcuberta

DOI
https://doi.org/10.3324/haematol.10358
Journal volume & issue
Vol. 92, no. 2

Abstract

Read online

Given that many cases of thrombosis do not have a clear cause, a myeloproliferative disease could be involved. We investigated the V617F mutation of the JAK2 gene in 295 patients with thrombosis. Only one case was positive. Therefore, the study of this mutation is not necessary in all patients with idiopathic thrombosis.